Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) Enterprise Value (2010 - 2026)

Curis' (CRIS) quarterly Enterprise Value came in at -$4.6 million in Q2 2026, up 48.25% on a YoY basis from -$3.1 million in Q2 2025, and up 68.19% quarter-over-quarter from -$14.5 million in Q1 2026.

Analysis

Curis (CRIS) Enterprise Value (2010 - 2026) Analysis & Trends

Curis (CRIS) has reported Enterprise Value for 17 consecutive years, with -$4.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Enterprise Value rose 48.25% year-over-year to -$4.6 million; the trailing twelve-month figure through Jun 2026 stood at -$4.6 million (up 48.25% YoY), and the FY2025 full-year result was -$4.4 million, up 76.76% from the prior year.
  • Enterprise Value improved to -$4.6 million in Q2 2026 per CRIS's latest filing, from -$14.5 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$4.4 million in Q4 2025 and bottomed at -$109.7 million in Q1 2022.
  • Historically, Enterprise Value has averaged -$44.4 million across 5 years, with a median of -$31.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Enterprise Value declined 4.92% in 2022, then surged 76.76% in 2025.
  • Over 5 years, Enterprise Value stood at -$83.0 million in 2022, then surged by 36.63% to -$52.6 million in 2023, then jumped by 63.8% to -$19.0 million in 2024, then soared by 76.76% to -$4.4 million in 2025, then retreated by 4.08% to -$4.6 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$4.6 million, -$14.5 million, and -$4.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Curis 2.63 Mn -2.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.60 Mn
Mar 31, 2026 -14.47 Mn
Dec 31, 2025 -4.42 Mn
Sep 30, 2025 -7.99 Mn
Jun 30, 2025 -8.90 Mn
Mar 31, 2025 -19.39 Mn
Dec 31, 2024 -19.03 Mn
Sep 30, 2024 -19.25 Mn
Jun 30, 2024 -26.32 Mn
Mar 31, 2024 -37.52 Mn
Dec 31, 2023 -52.58 Mn
Sep 30, 2023 -66.56 Mn
Jun 30, 2023 -59.36 Mn
Mar 31, 2023 -68.88 Mn
Dec 31, 2022 -82.97 Mn
Sep 30, 2022 -95.32 Mn
Jun 30, 2022 -102.68 Mn
Mar 31, 2022 -109.75 Mn
Dec 31, 2021 -94.07 Mn
Sep 30, 2021 -93.04 Mn